Telotristat ethyl: a new option for the management of carcinoid syndrome.

about

Medical Therapy of Gastrointestinal Neuroendocrine Tumors.Carcinoid-syndrome: recent advances, current status and controversies.Practical management of toxicities associated with targeted therapies for advanced gastroenteropancreatic neuroendocrine tumors.

P2860

Q47816626-1D20B648-296B-46EB-80CA-7B2B4DBF1B59 Q50094023-175E577B-7E25-4D3F-8D44-6110E1FAA9D1 Q55502689-92B89C64-6234-40A1-A7AA-C88A41B06700

P2860

Telotristat ethyl: a new option for the management of carcinoid syndrome.

Item

http://www.wikidata.org/entity/Q39000212

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Telotristat ethyl: a new option for the management of carcinoid syndrome.

@en

Telotristat ethyl: a new option for the management of carcinoid syndrome.

@nl

type

Item

label

Telotristat ethyl: a new option for the management of carcinoid syndrome.

@en

Telotristat ethyl: a new option for the management of carcinoid syndrome.

@nl

prefLabel

Telotristat ethyl: a new option for the management of carcinoid syndrome.

@en

Telotristat ethyl: a new option for the management of carcinoid syndrome.

@nl

P1476

Telotristat ethyl: a new option for the management of carcinoid syndrome

@en

P2093

Angela Lamarca

http://www.w3.org/2001/XMLSchema#string

Juan W Valle

http://www.w3.org/2001/XMLSchema#string

P2860

Disruption of the nonneuronal tph1 gene demonstrates the importance of peripheral serotonin in cardiac function

Gastrointestinal neuroendocrine tumors treated with high dose octreotide-LAR: a systematic literature review

Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids

GEP-NETS update: Interventional radiology: role in the treatment of liver metastases from GEP-NETs

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Lanreotide in metastatic enteropancreatic neuroendocrine tumors

Rationale for the use of somatostatin analogs as antitumor agents

Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system

Development and characterization of a novel in vivo model of carcinoid syndrome

Pharmacological reduction of mucosal but not neuronal serotonin opposes inflammation in mouse intestine.

P304

2487-2498

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14656566.2016.1254191

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jorge Barriuso

M G McNamara

Richard A Hubner

P577

2016-11-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27817224

http://www.w3.org/2001/XMLSchema#string

Telotristat ethyl: a new option for the management of carcinoid syndrome.

about

P2860

P2860

Telotristat ethyl: a new option for the management of carcinoid syndrome.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698